Published in Drug Alcohol Rev on May 01, 2010
The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS One (2013) 2.17
Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry (2014) 2.11
The co-occurring use and misuse of cannabis and tobacco: a review. Addiction (2012) 1.62
No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use. J Gen Intern Med (2013) 1.49
Marijuana use trajectories during the post-college transition: health outcomes in young adulthood. Drug Alcohol Depend (2012) 1.03
Alcohol and marijuana use patterns associated with unsafe driving among U.S. high school seniors: high use frequency, concurrent use, and simultaneous use. J Stud Alcohol Drugs (2014) 1.01
Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities. J Public Health (Oxf) (2015) 0.91
Acute effects of delta-9-tetrahydrocannabinol on performance monitoring in healthy volunteers. Front Behav Neurosci (2011) 0.86
Marijuana use and long-term mortality among survivors of acute myocardial infarction. Am Heart J (2012) 0.81
The Association between Cannabis Use, Mental Illness, and Suicidal Behavior: What is the Role of Hopelessness? Front Psychiatry (2013) 0.80
Medical marijuana programs - Why might they matter for public health and why should we better understand their impacts? Prev Med Rep (2015) 0.80
The relationship between cannabis involvement and suicidal thoughts and behaviors. Drug Alcohol Depend (2015) 0.79
Capsule commentary on Fuster et al., no detectable association between frequency of marijuana use and health or healthcare utilization among patients who screen positive for drug use. J Gen Intern Med (2014) 0.75
Safety and Toxicology of Cannabinoids. Neurotherapeutics (2015) 0.75
Excess mortality among people who report lifetime use of illegal drugs in the United States: A 20-year follow-up of a nationally representative survey. Drug Alcohol Depend (2016) 0.75
A virtue analysis of recreational marijuana use. Linacre Q (2016) 0.75
Marijuana Use and Perceptions of Risk and Harm: A Survey among Canadians in 2016. Healthc Policy (2017) 0.75
U.S. Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology (2017) 0.75
Drug abuse-associated mortality across the lifespan: a population-based longitudinal cohort and co-relative analysis. Soc Psychiatry Psychiatr Epidemiol (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (2008) 11.44
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Grand challenges in global mental health. Nature (2011) 8.40
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet (2010) 8.02
Effects of a sustained heroin shortage in three Australian States. Addiction (2005) 6.62
Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet (2012) 6.36
Adverse health effects of non-medical cannabis use. Lancet (2009) 6.25
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (2011) 6.21
An invitation to an alcohol industry lobby to help decide public funding of alcohol research and professional training: a decision that should be reversed. Addiction (2004) 5.61
A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A (2010) 4.94
Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. Addiction (2012) 3.91
Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (2013) 3.54
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ (2012) 3.46
The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med (2007) 3.45
Addiction, neuroscience and ethics. Addiction (2003) 3.44
The integrity of the science base: a test case. Addiction (2005) 3.40
Cannabis use and mental health in young people: cohort study. BMJ (2002) 3.26
Who is responsible for the public's health? The role of the alcohol industry in the WHO global strategy to reduce the harmful use of alcohol. Addiction (2013) 3.24
Health of the world's adolescents: a synthesis of internationally comparable data. Lancet (2012) 3.17
Exploring the association between cannabis use and depression. Addiction (2003) 2.92
Ethical concerns in the community about technologies to extend human life span. Am J Bioeth (2009) 2.87
Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction (2005) 2.74
Recent increase in detection of alprazolam in Victorian heroin-related deaths. Med J Aust (2013) 2.71
Heroin overdose: research and evidence-based intervention. J Urban Health (2003) 2.66
Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study. Br J Psychiatry (2003) 2.57
Is cannabis use a contributory cause of psychosis? Can J Psychiatry (2006) 2.42
The ratio of non-fatal to fatal heroin overdose. Addiction (2003) 2.38
Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database. Pain (2009) 2.37
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend (2009) 2.20
Proposals to trial deep brain stimulation to treat addiction are premature. Addiction (2011) 2.17
Compulsory detention, forced detoxification and enforced labour are not ethically acceptable or effective ways to treat addiction. Addiction (2012) 2.15
Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction (2010) 2.14
A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend (2003) 2.05
Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ (2013) 1.95
A longitudinal study of the effects of adolescent cannabis use on high school completion. Addiction (2003) 1.91
Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health (2002) 1.89
The increasing mortality burden of liver disease among opioid-dependent people: cohort study. Addiction (2011) 1.87
Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health (2011) 1.81
Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain (2008) 1.75
Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry (2010) 1.66
Causes of death in a cohort treated for opioid dependence between 1985 and 2005. Addiction (2013) 1.64
The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain (2015) 1.62
Trajectories of adolescent alcohol and cannabis use into young adulthood. Addiction (2007) 1.60
Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry (2007) 1.59
Mental health of teenagers who use cannabis. Results of an Australian survey. Br J Psychiatry (2002) 1.59
Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev (2005) 1.57
The association between delusional-like experiences, and tobacco, alcohol or cannabis use: a nationwide population-based survey. BMC Psychiatry (2011) 1.54
Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. Int J Drug Policy (2009) 1.53
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev (2005) 1.50
Opioid dependence latent structure: two classes with differing severity? Addiction (2010) 1.49
Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend (2003) 1.49
Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med (2014) 1.49
Cannabis dependence in young adults: an Australian population study. Addiction (2002) 1.47
Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy. Drug Alcohol Rev (2008) 1.44
Exposure to opioid maintenance treatment reduces long-term mortality. Addiction (2008) 1.44
What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend (2011) 1.43
Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Addiction (2002) 1.42
The five-factor model of personality and borderline personality disorder: a genetic analysis of comorbidity. Biol Psychiatry (2009) 1.42
Drug trafficking: time to abolish the death penalty. Addiction (2009) 1.41
Standardizing terminology in addiction science: to achieve the impossible dream. Addiction (2007) 1.39
UK classification of cannabis: is a change needed and why? Lancet (2007) 1.38
Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction (2008) 1.35
Systematic review of interventions to improve prescribing. Ann Pharmacother (2009) 1.35
Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Rev (2011) 1.34
The structure of cannabis dependence in the community. Drug Alcohol Depend (2002) 1.32
One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend (2005) 1.31
What are the policy implications of the evidence on cannabis and psychosis? Can J Psychiatry (2006) 1.31
Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey. Addiction (2009) 1.29
HIV due to female sex work: regional and global estimates. PLoS One (2013) 1.29
Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence. Addict Behav (2010) 1.27
Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug Alcohol Depend (2003) 1.24
Sociodemographic predictors of transitions across stages of alcohol use, disorders, and remission in the National Comorbidity Survey Replication. Compr Psychiatry (2008) 1.24
Mortality among amphetamine users: a systematic review of cohort studies. Drug Alcohol Depend (2009) 1.21
Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug Alcohol Depend (2005) 1.20
Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction (2010) 1.20
Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data. PLoS One (2012) 1.19
A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf (2009) 1.18